CACLP - The largest IVD Expo & Conference

In Vitro Diagnostic Industry in China - Clinical Chemistry IV

Industry news | 07 May, 2024 | CACLP
2.    Status Quo and Development of Biochemical Reagents
2.1 Overview
Biochemical diagnostic reagents, as one of the main categories of diagnostic reagents, are characterized by a large population coverage, a high proportion of services and service users and a huge market size. From 2015 to 2020, the market size of biochemical diagnostic reagents has increased year by year in China; in 2020, the market size of biochemical diagnostic reagents is about 16.1 billion CNY in China. The localization of biochemical reagents has been basically realized and they have been sold to Grade IlI Level A hospitals, and the import monopoly has been broken by domestic enterprises. Presently, about 70% of the market share has been occupied by domestic brands, and the rest is occupied by some powerful multinational corporations (such as Beckman, RANDOX, Toagosei). The domestic leaders of biochemical reagents mainly include BSBE, Medicalsystem, Leadman, Maccura, Zybio, and other open reagent R&D manufacturers.
 
Taking homocysteine as an example, the abnormal blood homocysteine metabolism leads to the elevated concentration of homocysteine, which will greatly increase the risk of coronary heart disease, peripheral vascular disease, and cerebrovascular disease. Therefore, homocysteine is an important parameter of human health condition. Based on the data of CFDA, there are 12 foreign enterprises and 207 domestic enterprises that produce the homocysteine kit (enzymatic cycling assay) in 2020. 
 
 
The above figure shows that the main manufacturers are distributed in Zhejiang, Guangdong, Beijing, Jiangsu, Shanghai, etc. Geographically, these manufacturers of biochemical reagents are mainly located in the eastern and southern coastal areas. The top 7 provinces and cities in terms of the number of enterprises account for more than 70% of the national market share, revealing a high degree of geographic concentration in the industry. The production and operation enterprises are mainly distributed in the Pearl River Delta, the Yangtze River Delta, and the Beijing-Tianjin-Hebei region, with the number of enterprises ranking the top nationwide.
 
Last: In Vitro Diagnostic Industry in China - Clinical Chemistry III
Next: In Vitro Diagnostic Industry in China - Clinical Chemistry V
Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference